Showing 1 - 14 results of 14 for search 'Marion Thibaudin', query time: 0.06s
Refine Results
-
1
Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer by Marion Thibaudin, Francois Ghiringhelli
Published 2023-12-01
Article -
2
-
3
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carrier... by Jean-David Fumet, Emeric Limagne, Marion Thibaudin, Caroline Truntzer, Aurélie Bertaut, Emilie Rederstorff, Francois Ghiringhelli
Published 2020-08-01
Article -
4
Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer by Francois Ghiringhelli, Valentin Derangere, Quentin Klopfenstein, Emeric Limagne, Marion Thibaudin, Caroline Truntzer, Laurent Arnould, Sylvain Ladoire
Published 2021-06-01
Article -
5
346 Translational program of the phase II MEDITREME trial: identification of prognostic factors for response to durvalumab and tremelimumab in combination with FOLFOX in metastatic... by Francois Ghiringhelli, Emeric Limagne, Marion Thibaudin, Caroline Truntzer, Olivier Adotevi, Caroline Laheurte, Elise Ballot, Jean-David Fumet
Published 2021-11-01Article -
6
Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients by Emeric Limagne, Corentin Richard, Marion Thibaudin, Jean-David Fumet, Caroline Truntzer, Aurélie Lagrange, Laure Favier, Bruno Coudert, François Ghiringhelli
Published 2019-04-01
Article -
7
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation by Emeric Limagne, Marion Thibaudin, Romain Euvrard, Hélène Berger, Pauline Chalons, Frédérique Végan, Etienne Humblin, Romain Boidot, Cédric Rébé, Valentin Derangère, Sylvain Ladoire, Lionel Apetoh, Dominique Delmas, François Ghiringhelli
Published 2017-04-01
Article -
8
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination by Mathieu Grapin, Corentin Richard, Emeric Limagne, Romain Boidot, Véronique Morgand, Aurélie Bertaut, Valentin Derangere, Pierre-Antoine Laurent, Marion Thibaudin, Jean David Fumet, Gilles Crehange, François Ghiringhelli, Céline Mirjolet
Published 2019-06-01
Article -
9
Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance by Alexia Karen Cotte, Virginie Aires, Maxime Fredon, Emeric Limagne, Valentin Derangère, Marion Thibaudin, Etienne Humblin, Alessandra Scagliarini, Jean-Paul Pais de Barros, Patrick Hillon, François Ghiringhelli, Dominique Delmas
Published 2018-01-01
Article -
10
IRF8-dependent molecular complexes control the Th9 transcriptional program by Etienne Humblin, Marion Thibaudin, Fanny Chalmin, Valentin Derangère, Emeric Limagne, Corentin Richard, Richard A. Flavell, Sandy Chevrier, Sylvain Ladoire, Hélène Berger, Romain Boidot, Lionel Apetoh, Frédérique Végran, François Ghiringhelli
Published 2017-12-01
Article -
11
Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy by Francois Ghiringhelli, Valentin Derangere, Marion Thibaudin, Caroline Truntzer, Bertrand Routy, Fanny Chalmin, Cédric Rébé, Julie Niogret, Hélène Berger, Romain Mary, Elise Ballot, Christophe Hibos, Léa Hampe, David Rageot, Théo Accogli, Philippe Joubert, James Harker, Frederique Vegran
Published 2021-06-01
Article -
12
Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial by Marion Thibaudin, Nicolas Roussot, Chloé Burlot, Antonin Schmitt, Julie Vincent, Zoé Tharin, Leila Bengrine, Hélène Bellio, Aurélie Bertaut, Léa Hampe, Susy Daumoine, Emilie Rederstorff, Morgane Peroz, Titouan Huppe, Valentin Derangère, David Rageot, John Simard, Caroline Truntzer, Jean David Fumet, Francois Ghiringhelli
Published 2025-01-01
Article -
13
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer by Nicolas Roussot, Jean-David Fumet, Emeric Limagne, Marion Thibaudin, Alice Hervieu, Audrey Hennequin, Sylvie Zanetta, Lorraine Dalens, Théo Fourrier, Loick Galland, Pierre Jacob, Aurélie Bertaut, Emilie Rederstorff, Cédric Chevalier, Sarah Ghirardi, Elodie Gilbert, Azzat Khoukaz, Etienne Martin, Constance Nicolet, Magali Quivrin, David Thibouw, Noémie Vulquin, Gilles Truc, Magali Rouffiac, Francois Ghiringhelli, Céline Mirjolet
Published 2023-11-01
Article -
14
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC by Nicolas Roussot, Nicolas Roussot, Nicolas Roussot, Nicolas Roussot, Marion Thibaudin, Marion Thibaudin, Jean-David Fumet, Jean-David Fumet, Jean-David Fumet, Jean-David Fumet, Susy Daumoine, Susy Daumoine, Léa Hampe, Léa Hampe, Cédric Rébé, Cédric Rébé, Emeric Limagne, Emeric Limagne, Emeric Limagne, Aurélie Lagrange, Victor Herreros, Julie Lecuelle, Julie Lecuelle, Hugo Mananet, Hugo Mananet, Alis Ilie, Alis Ilie, David Rageot, David Rageot, Romain Boidot, Romain Boidot, Vincent Goussot, Anthony Comte, Pierre Jacob, Pierre Jacob, Pierre Jacob, Pierre Jacob, Françoise Beltjens, Anthony Bergeron, Céline Charon-Barra, Laurent Arnould, Valentin Derangère, Valentin Derangère, Valentin Derangère, Sylvain Ladoire, Sylvain Ladoire, Sylvain Ladoire, Sylvain Ladoire, Caroline Truntzer, Caroline Truntzer, François Ghiringhelli, François Ghiringhelli, François Ghiringhelli, François Ghiringhelli
Published 2024-08-01
Article